ABL Bio ranked among the top searched stocks on 4 days in the past month.

As of 1:30 PM on the 12th, ABL Bio is trading at 29,100 KRW, down 2.18% from the previous day. This represents a 59.89% increase compared to May 27. ABL Bio is known as a specialized company developing biopharmaceuticals based on antibody therapeutics.

Today, foreigners have a net purchase of 50,000 shares of ABL Bio, and institutions have a net purchase of 8,000 shares, according to provisional data. Over the past 5 days, individual investors have net purchased 439,407 shares, while foreigners and institutions have net purchased 297,550 shares and net sold 597,372 shares, respectively.

On June 11, ABL Bio was a market topic for its strong performance driven by the advancement of its "bispecific antibody platform technology" transfer.



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing